Research & Development

Tampa General Gets C Grade in Hospital Safety; Other FL Hospitals Excel
Research & Development Tampa General Gets C Grade in Hospital Safety; Other FL Hospitals Excel

The recent hospital safety ratings in Florida have sparked significant discussion, especially with Tampa General Hospital receiving a C grade from Leapfrog, an independent nonprofit that rates hospital safety. This rating marks the fifth time in the last six Leapfrog assessments that the hospital

Can VirtuDockDL Transform Drug Discovery with Deep Learning and GNNs?
Research & Development Can VirtuDockDL Transform Drug Discovery with Deep Learning and GNNs?

The landscape of drug discovery is poised for a significant transformation with the advent of VirtuDockDL, a groundbreaking Python-based platform driven by deep learning and graph neural networks (GNNs). Developed through a collaborative effort by researchers from The University of Lahore,

How Far Will Pet Owners Go to Save Their Beloved Animals?
Research & Development How Far Will Pet Owners Go to Save Their Beloved Animals?

Stéphanie Gauvin and Tim MacIsaac, a devoted couple hailing from Nova Scotia, have embarked on a challenging and emotional journey to save their five-year-old golden doodle, Lucy, diagnosed with T-cell lymphoma. In their quest to find the best possible treatment for Lucy, they have encountered

Can Engineered Salmonella Bacteria Revolutionize Bowel Cancer Treatment?
Research & Development Can Engineered Salmonella Bacteria Revolutionize Bowel Cancer Treatment?

Groundbreaking research, funded by Cancer Research UK and conducted by teams from the Cancer Research UK Scotland Institute in Glasgow and the University of Birmingham, has uncovered innovative ways to potentially use salmonella bacteria to combat bowel cancer. Historically known for causing food

Johnson & Johnson's Icotrokinra Shows Success in Plaque Psoriasis Trial
Research & Development Johnson & Johnson's Icotrokinra Shows Success in Plaque Psoriasis Trial

Johnson & Johnson (J&J) has announced promising topline results from its Phase III ICONIC-LEAD trial evaluating icotrokinra (JNJ-2113) for the treatment of moderate to severe plaque psoriasis in patients aged 12 and older. The study revealed that 64.7% of participants treated with icotrokinra

Can COVID-19 Immune Response Lead to Cancer Treatment Breakthroughs?
Research & Development Can COVID-19 Immune Response Lead to Cancer Treatment Breakthroughs?

The COVID-19 pandemic has brought unprecedented challenges to global health, but recent research suggests it may also offer unexpected benefits. Scientists from the Northwestern Medicine Canning Thoracic Institute have discovered a surprising link between the immune response to COVID-19 and cancer

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later